BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 34582363)

  • 1. Identification of genes and pathways leading to metastasis and poor prognosis in melanoma.
    Zhang X; Wang W; Wang Y; Jiang G
    Aging (Albany NY); 2021 Sep; 13(18):22474-22489. PubMed ID: 34582363
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key candidate genes involved in melanoma metastasis.
    Chen J; Wu F; Shi Y; Yang D; Xu M; Lai Y; Liu Y
    Mol Med Rep; 2019 Aug; 20(2):903-914. PubMed ID: 31173190
    [TBL] [Abstract][Full Text] [Related]  

  • 3. BRAFV600E cooperates with PI3K signaling, independent of AKT, to regulate melanoma cell proliferation.
    Silva JM; Bulman C; McMahon M
    Mol Cancer Res; 2014 Mar; 12(3):447-63. PubMed ID: 24425783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STAT3-induced upregulation of lncRNA SNHG17 predicts a poor prognosis of melanoma and promotes cell proliferation and metastasis through regulating PI3K-AKT pathway.
    Gao H; Liu R; Sun X
    Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):8000-8010. PubMed ID: 31599425
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulation of lncRNA H19 inhibits the migration and invasion of melanoma cells by inactivating the NF‑κB and PI3K/Akt signaling pathways.
    Liao Z; Zhao J; Yang Y
    Mol Med Rep; 2018 May; 17(5):7313-7318. PubMed ID: 29568965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-92a promotes epithelial-mesenchymal transition through activation of PTEN/PI3K/AKT signaling pathway in non-small cell lung cancer metastasis.
    Lu C; Shan Z; Hong J; Yang L
    Int J Oncol; 2017 Jul; 51(1):235-244. PubMed ID: 28534966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNA-194 regulates human melanoma cells via PI3K/AKT/FoxO3a and p53/p21 signaling pathway.
    Bai M; Zhang M; Long F; Yu N; Zeng A; Zhao R
    Oncol Rep; 2017 May; 37(5):2702-2710. PubMed ID: 28358423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioinformatics-based analysis reveals elevated MFSD12 as a key promoter of cell proliferation and a potential therapeutic target in melanoma.
    Wei CY; Zhu MX; Lu NH; Peng R; Yang X; Zhang PF; Wang L; Gu JY
    Oncogene; 2019 Mar; 38(11):1876-1891. PubMed ID: 30385854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage migration inhibitory factor engages PI3K/Akt signalling and is a prognostic factor in metastatic melanoma.
    Oliveira CS; de Bock CE; Molloy TJ; Sadeqzadeh E; Geng XY; Hersey P; Zhang XD; Thorne RF
    BMC Cancer; 2014 Aug; 14():630. PubMed ID: 25168062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BRAF, KIT and NRAS mutations and expression of c-KIT, phosphorylated extracellular signal-regulated kinase and phosphorylated AKT in Japanese melanoma patients.
    Oyama S; Funasaka Y; Watanabe A; Takizawa T; Kawana S; Saeki H
    J Dermatol; 2015 May; 42(5):477-84. PubMed ID: 25766129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting GOLM1 by microRNA-200a in melanoma suppresses cell proliferation, invasion and migration via regulating PI3K/Akt signaling pathway and epithelial-mesenchymal transition.
    Chen WY; Xu YY; Zhang XY
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6997-7007. PubMed ID: 31486500
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RhoC promotes human melanoma invasion in a PI3K/Akt-dependent pathway.
    Ruth MC; Xu Y; Maxwell IH; Ahn NG; Norris DA; Shellman YG
    J Invest Dermatol; 2006 Apr; 126(4):862-8. PubMed ID: 16470169
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of mTOR Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K-AKT-mTOR Pathway Inhibitors.
    Kong Y; Si L; Li Y; Wu X; Xu X; Dai J; Tang H; Ma M; Chi Z; Sheng X; Cui C; Guo J
    Clin Cancer Res; 2016 Feb; 22(4):1018-27. PubMed ID: 26490311
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of miR‑542‑3p in osteosarcoma with miRNA microarray data, and its potential signaling pathways.
    Li Z; Yao JN; Huang WT; He RQ; Ma J; Chen G; Wei QJ
    Mol Med Rep; 2019 Feb; 19(2):974-983. PubMed ID: 30569116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. AKT1 as the PageRank hub gene is associated with melanoma and its functional annotation is highly related to the estrogen signaling pathway that may regulate the growth of melanoma.
    Zhao J; Zeng X; Song P; Wu X; Shi H
    Oncol Rep; 2016 Oct; 36(4):2087-93. PubMed ID: 27573172
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Pivotal MicroRNAs and Target Genes Associated with Persistent Atrial Fibrillation Based on Bioinformatics Analysis.
    Xiao S; Zhou Y; Liu Q; Zhang T; Pan D
    Comput Math Methods Med; 2021; 2021():6680211. PubMed ID: 33747117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXC1 promotes melanoma by activating MST1R/PI3K/AKT.
    Wang J; Li L; Liu S; Zhao Y; Wang L; Du G
    Oncotarget; 2016 Dec; 7(51):84375-84387. PubMed ID: 27533251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatics analysis to identify the critical genes, microRNAs and long noncoding RNAs in melanoma.
    Zhang Q; Wang Y; Liang J; Tian Y; Zhang Y; Tao K
    Medicine (Baltimore); 2017 Jul; 96(29):e7497. PubMed ID: 28723760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identifying the key genes and microRNAs in colorectal cancer liver metastasis by bioinformatics analysis and in vitro experiments.
    Zhang T; Guo J; Gu J; Wang Z; Wang G; Li H; Wang J
    Oncol Rep; 2019 Jan; 41(1):279-291. PubMed ID: 30542696
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-139-5p modulates the growth and metastasis of malignant melanoma cells via the PI3K/AKT signaling pathway by binding to IGF1R.
    Yang C; Xia Z; Zhu L; Li Y; Zheng Z; Liang J; Wu L
    Cell Cycle; 2019 Dec; 18(24):3513-3524. PubMed ID: 31724454
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.